Caplin Point Laboratories LimitedNSE: CAPLIPOINT

Press Release Oct 23 2025

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated October 23, 2025, titled "CAPLIN STERILES GETS USFDA APPROVAL FOR NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION, INFUSION BAGS".

View Attachment

Earlier from Caplin Point Laboratories

All Caplin Point Laboratories news releases